1 - 5 of
5 for companies in category
Analysis in
Canada:
Developer, manufacturer and distributor of innovative sample preparation devices for high sensitive mass spectrometry and liquid chromatography.
The core of the company's product line is their proprietary Diffractive Optics Technology - or dot™ - which combines two proven technologies - the diffraction of light and immobilized capture surfaces - to provide a simple, sensitive, and cost-effective technique for the real-time detection of biomolecular interactions and immunoassays without the use of labels.
Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).
DiagnoCure has specialized in the development, production and commercialization of molecular diagnostics for the detection and management of cancer
Epocal is implementing an entire blood diagnostic 'laboratory on a chip' in FlexCard™ technology, with some elements are fabricated in media with micrometer or nanometer scale flow channels or pores.
[First Page] [Prev] Showing page 1 of 1 pages [Next] [Last Page]
